Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
Quick Stats
Feb 02, 202656.6
AI Score
HOLD0.24
Volume Ratio
Feb 25, 2026
Next Earnings
21
+ve Days (30d)
9
-ve Days (30d)
GLSI Stock Summary
Last updated Feb 02, 2026
GLSI is currently trading at $31.8, positioned above its 200-day moving average of $12.16, indicating a long-term uptrend. The stock has a 52-week range of $7.78 to $34.1.
Technical Analysis: The 50-day moving average stands at $17.8, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 64.018, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.194, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates GLSI at 56.6/100 with a HOLD recommendation.
GLSI (Greenwich LifeSciences, Inc.) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 64.018 |
| CMF (20) | -0.194 |
| ROC (10) | 27.814 |
| ADX (14) | 57.257 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 3.555 |
| AROONOSC (14) | 28.571 |
| WILLAMS %R (14) | -16.312 |
| MFI (14) | 66.087 |
GLSI Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GLSI Price vs Max Options Open Interest
GLSI Max Change In Options Open Interest
GLSI Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GLSI Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GLSI Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GLSI Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Greenwich LifeSciences, Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
GLSI Moving Averages Analysis
Greenwich LifeSciences, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026
Greenwich LifeSciences, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
GLSI (Greenwich LifeSciences, Inc.) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 27.75 |
| 20 | 26.46 |
| 30 | 23.58 |
| 50 | 17.8 |
| 100 | 13.87 |
| 200 | 12.16 |
GLSI Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 416.6 million |
| Earnings/Share ($) | -1.46 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.225 |
| EPS Estimate Next Year ($) | -1.36 |
| WallStreet Target Price ($) | 47.5 |
| Most Recent Quarter |